Search for content, post, videos

Positive results from Scandion Oncology and Alligator Bioscience

Søren Bregenholt
Alligator Bioscience and Scandion Oncology have announced the conclusion of their collaboration with a very positive outcome. The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.